Patents Assigned to MANKIND PHARMA LTD
  • NOVEL APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS
    Publication number: 20220332700
    Abstract: The present invention relates to inhibitors of apoptosis signal-regulating kinase 1 (“ASK1”), a process for synthesis of the compounds of the present invention, composition comprising the compounds and use of the compounds for inhibition of ASK1.
    Type: Application
    Filed: June 24, 2020
    Publication date: October 20, 2022
    Applicant: MANKIND PHARMA LTD
    Inventors: Santosh Kumar RAI, Rakesh Iswar PATIL, Somnath Singha ROY, Kalicharan SHARMA, Rahul DWIVEDI, Srinivasa Reddy BAPURAM, Anil KUMAR
  • Fluoroquinolone carboxylic acid compounds and use thereof for the preparation of besifloxacin hydrochloride
    Patent number: 10167271
    Abstract: The present invention relates to novel fluoroquinolone carboxylic acid compounds and derivatives of Formula-I, and their salts wherein, R represents H or halogen. The present invention also relates to the use of novel fluoroquinolone carboxylic acid compounds and derivatives of Formula-I for preparation of Besifloxacin hydrochloride.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: January 1, 2019
    Assignee: MANKIND PHARMA LTD
    Inventors: Jigar Bhavsar, Bhuwan Bhashkar, Anil Kumar